The Repurposing Generic (ReGen) Drugs Evidence Package Challenge from NIH Challenges seeks strong scientific evidence for generic drugs as affordable treatments for costly diseases.
Cures Within Reach funds clinical trials using AI to validate repurposed therapies for unsolved diseases, prioritizing rare conditions and explainable AI workflows.
Repurposing Research for Chicago 2026: Track 2 – Patient Groups supports Chicago-area researchers testing repurposed therapies to address unsolved diseases in underserved and priority patient groups.
FDA grant supports collaborative projects to advance drug development, manufacturing, and regulatory science, focusing on safety, efficacy, and innovation.
This upcoming NIH grant will fund innovative preclinical research to develop new methods or agents that selectively target "undruggable" molecules involved in difficult-to-treat human diseases.